
Definitive Diagnostics, Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingNew York, NY
Founded
2023
Primary NAICS
325413
CAGE code
9VJY2
Federal awards
—
Overview
Definitive Diagnostics develops an AI-enabled, protein-based blood test platform for earlier cancer detection, reducing false positives and improving accuracy.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)